Medical device housing
Description
The dot-dash broken lines represent boundaries of the claimed design and form no part thereof. All other broken lines illustrate portions of the medical device housing that form no part of the claimed design.
Claims
The ornamental design for a medical device housing, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
| D228970 | October 1973 | Cohen |
| D445895 | July 31, 2001 | Svendsen |
| D737952 | September 1, 2015 | Matsumura |
| D739005 | September 15, 2015 | Matsumura |
| D922562 | June 15, 2021 | Hulford et al. |
| 11324940 | May 10, 2022 | Earls |
| D1022191 | April 9, 2024 | Wood |
| D1022193 | April 9, 2024 | Haller |
| D1034963 | July 9, 2024 | Piccimimi |
| D1066653 | March 11, 2025 | Wood |
| D1068068 | March 25, 2025 | Wood |
| D1090825 | August 26, 2025 | Loughlin |
| D1092716 | September 9, 2025 | Bernazani |
| D1098444 | October 14, 2025 | Qi |
| D1101157 | November 4, 2025 | Qi |
| 12544557 | February 10, 2026 | Lee |
| D1129652 | June 9, 2026 | Schoeps |
| 20030187322 | October 2, 2003 | Siess |
| 20100041939 | February 18, 2010 | Siess |
| 20150328383 | November 19, 2015 | Corbett |
| 20180228953 | August 16, 2018 | Siess |
| 20210100940 | April 8, 2021 | Breidall |
| 20210196941 | July 1, 2021 | Bernazani |
| 20210268264 | September 2, 2021 | Stotz |
| 20220040472 | February 10, 2022 | Corbett |
| 20220161018 | May 26, 2022 | Mitze |
| 20250121179 | April 17, 2025 | Qi |
| 20250170388 | May 29, 2025 | Kerkhoffs |
| 20250367428 | December 4, 2025 | Yu |
| 20260000885 | January 1, 2026 | Siess |
| 20260048253 | February 19, 2026 | Corbett |
| 20260091218 | April 2, 2026 | Perkins |
| 20260137927 | May 21, 2026 | Zhu |
| 20260158262 | June 11, 2026 | Shireman |
| 306163859 | November 2020 | CN |
| 2022102753039 | March 2022 | CN |
| 015063303-0003 | May 2025 | EM |
| D1659556 | May 2020 | JP |
| D1770274 | May 2024 | JP |
| 1773800 | June 2024 | JP |
| D1773800 | June 2024 | JP |
| 3000958130000 | July 1988 | KR |
| 301099179.0000 | March 2021 | KR |
| D199557 | September 2019 | TW |
| 112303582 | August 2024 | TW |
- Citoday, FDA Approves Abiomed's Recover IV RCT With Exception From Informed Consent, Pub: Sep. 16, 2022, citoday.com, Retrieved from: https://citoday.com/news/fda-approves-abiomeds-recover-iv-rct-with-exception-from-informed-consent (Year: 2022).
- DAIC, Abiomed Receives Expanded Impella Approval for Cardiomyopathy With Cardiogenic Shock, Pub: Feb. 15, 2018, dicardiology.com, Retrieved from: https://www.dicardiology.com/content/abiomed-receives-expanded-impella-approval-cardiomyopathy-cardiogenic-shock (Year: 2018).
- Van Edom, Bleeding and Hemolysis Management During pVAD Support, Pub: Jul. 24, 2023, JACC, Retrieved from: https://www.jacc.org/doi/epdf/10.1016/j.jcin.2023.05.043 (Year: 2023).
- Notice of Reference corresponding to Japanese Design Application No. 2024-023261, dated Nov. 28, 2024.
- Taiwanese Search Report for corresponding Taiwanese Application No. 114301929 dated May 14, 2025.
- Zein, “A Review of the Impella Devices”, Published: Apr. 8, 2022, icrjournal.com, Retrieved from: https://www.icrjournal.com/articles/review-impella-devices?language_content_entity=en (Year: 2022).
- Fornell, “Photo Gallery of the Abiomed Impella Production Line”, Published: Feb. 10, 2020, dicardiology.com, Retrieved from: https:/1WINW.dicardiology.com/contenUphoto-gallery-abiomed-impella-production-line (Year:2020).
- Abiomed, Abiomed SmartAssist Platform Press Release, Published: Sep. 17, 2019, abiomed.com, Retrieved from: https://www.abiomed.com/en-us/about-us/news-and-media/press-releases/abiomed-highlight-importance-optimal-pci-treatment-improve-outcomes-high-risk (Year: 2019).
Patent History
Patent number: D1156643
Type: Grant
Filed: Oct 7, 2025
Date of Patent: Nov 3, 2026
Assignee: ABIOMED, INC. (Danvers, MA)
Inventors: Zhongwei Qi (Danvers, MA), Scott Corbett (Danvers, MA)
Primary Examiner: Daniel J Domino
Assistant Examiner: Edward P Jones
Application Number: 30/026,903
Type: Grant
Filed: Oct 7, 2025
Date of Patent: Nov 3, 2026
Assignee: ABIOMED, INC. (Danvers, MA)
Inventors: Zhongwei Qi (Danvers, MA), Scott Corbett (Danvers, MA)
Primary Examiner: Daniel J Domino
Assistant Examiner: Edward P Jones
Application Number: 30/026,903
Classifications